Can a High-Tech patch help underserved diabetes patients control blood sugar?
NCT ID NCT05766488
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a continuous glucose monitor (CGM) – a small sensor worn on the arm that checks blood sugar constantly – can help underserved patients with type 2 diabetes better manage their condition compared to traditional finger-stick testing. Fifty adults with poorly controlled diabetes (A1c over 9%) will use either a CGM or a standard glucometer for 6 months. Researchers will track changes in blood sugar levels and how often dangerously low blood sugar occurs.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Continuous Glucose Monitor (Freestyle Libre 2)
What this could lead to
If successful, this could show that continuous glucose monitors improve blood sugar control in underserved patients with type 2 diabetes, potentially leading to wider access and better care.
What could go wrong
This is a small, early-stage study with only 50 participants, so results may not apply to everyone. The device may be difficult for some patients to use consistently, and the study does not test long-term outcomes beyond 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nebraska Medicine
Omaha, Nebraska, 68198-7400D, United States